9th Annual BioPartnering North America™
Vancouver Convention Centre | Vancouver, BC, Canada
27 February - 1 March 2011
 |
 |
 |
||
 |
 testimonial
"Good networking events and possibilities. The size of the meeting is very conducive to interaction with other participants."Dr. Michele Beaulieu Officer Life Sciences Technologies McGill University testimonial
"BPN helped us promote company awareness as well as identify and connect with potential strategic alliances over one-on-one meetings."Sanah Jowhari TheraCarb Inc PROGRAM QUESTIONS? Rebecca Angelos Operations & Conference Director Phone: +1.831.464.4230 x153
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |  |
Connect with fellow delegates on Sunday evening before BPN begins, over drinks and appetizers at the Westin Bayshore Grand Foyer. The Bayshore is tucked away in picturesque Coal Harbour and offers an unparalleled location with panoramic views of the coastline, mountains and historic Stanley Park.
Monday, 25 January
07:30-16:00 Registration
- Foyer Hallway
07:30-10:30 Italian-Style Breakfast
- Grand Foyer
| Sponsored by: |  |
Join us in the Grand Foyer for a breakfast inspired by the culinary delights of Italy! Help yourselves to brioche bread and freshly baked croissants with fruit preserves, creamery butter, and honey. Satisfy your taste buds with muesli cereal and fresh fruits and berries. Assorted juices, teas, and freshly-brewed Starbucks coffee will also be available.
Stop by the Italian Trade Commission's exhibit booth in Salon D to express your appreciation for breakfast!
08:00-08:15 Conference Welcome
- Salons E & F
BPN is now the largest life science partnering event in the USA and Canada, and continues to attract some of the most promising life science companies from around the world, with a strong presence from the host provinces of British Columbia and Alberta, as well as the host nation, Canada. With the support of the innovative networking software product, biopartnering.com™, more companies than ever before are scheduling valuable face-to-face meetings with efficiency and ease. In a turbulent world economy, forming partnerships is now more important than at any time in the history of BPN.
Speaker: Mr. Peter Brenders, President & CEO, BIOTECanada
Speaker: Ms. Karimah Es Sabar, President, LifeSciences British Columbia
Speaker: Dr. Robert Lee Kilpatrick, Partner, TVG
Speaker: Mr. Ryan Radke, President, BioAlberta
Speaker: The Honourable Dr. Moira Stilwell, Minister of Advanced Education and Labour Market Development, Vancouver-Langara
08:15-09:00 Keynote Address
- Salons E & F
Title:
09:00-17:30 Exhibition Hall: Spotlight on Biotechnology
- Salon D
1. Pharmatek Laboratories, Inc. - USA
2. Globe Laboratories Inc - Canada
3. Department of Biotechnology and Confederation of Indian Industry - Canada
4. Silence Therapeutics AG - Germany
5. Italian Trade Commission - Ontario
6. French Trade Commission - UBIFRANCE - Canada
7. BioCentury Publications - USA
8. Deloitte - USA
9. Alphora Research Inc. - Canada
10. PROOF Centre of Excellence - Canada
11. Piramal Healthcare - Canada
12. Korea International Trade Association (KITA) - Korea
13. CIRION Clinical Trial Services - Canada
14. Zoomedia - USA
09:30-12:15 Podium Presentations - Stream 1
- Cowichan Room
In this dedicated presentation room, biotechnology companies from around the world will introduce their companies, their key technologies, products and clinical developments, as well as state their companies' partnering and financing goals.
09:30 Vivalis - France
09:45 AVOGADRO - France
10:00 Plant Advanced Technologies - France
10:15 Prestwick Chemical - France
10:30 TFChem - France
10:45 Eurofins-Adme Bioanalyses - France
11:00 PX'Therapeutics - France
11:15 Novalix - France
11:30 XenTech - France
11:45 NicOx SA - France
12:00 Oncodesign - France
09:30-12:15 Podium Presentations - Stream 2
- Coquitlam Room
In this dedicated presentation room, biotechnology companies from around the world will introduce their companies, their key technologies, products and clinical developments, as well as state their companies' partnering and financing goals.
09:30 PlantForm - Canada
09:45 Pearl Therapeutics, Inc. - USA
10:00 DSM Biologics - USA
10:15 Inovio Biomedical Corporation - USA
10:30 i3 CanReg - Canada
10:45 Immunovaccine Inc. - Canada
11:00 Allphase Clinical Research Inc. - Canada
11:15 NeuMedics Inc. - USA
11:30 Skunkwerks Software Ltd - Canada
11:45 AltheaDx - USA
12:00 ACT Biotech - USA
10:00-11:30 Workshop - hosted by EFB & Medicon Valley
- Mackenzie Room
Title: Surviving Beyond 2010 - The Importance of Global Networks to the Future of the Life Science Industry
| As an indication of the current state of most life science clusters around the world, attend this workshop to hear the results of a recent study of the biotech industry in Scandinavia, going into 2010. A panel of executives from leading companies who believe that global networks are the only way forward will briefly introduce their perspective and give you a sense of what is happening in the US and in Europe, and indeed around the world. Learn about how two organizations have developed international networks to help their life science community thrive and succeed in this economy. Expect an open and engaging audience / panel discussion of how the future of global networks will move the life sciences industry forward. |
|
Chair: Mr. Soren Harbel, Ambassador, LifeSciences British Columbia
Chair: Mr. Jens Sundbye, CEO, European Federation of Biotechnology / BioMedico Forum
Speaker: Ms. Karimah Es Sabar, President, LifeSciences British Columbia
Speaker: Dr. Finn Benned Hansen, Vice President and Head of Business Development, NOVO Nordisk
Speaker: Ms. Lena Martensson, Pre-Clinical, AstraZeneca
Speaker: Dr. Simon Pimstone, President & Chief Executive Officer, Xenon
10:30-17:30 Coffee & Tea Service
- Grand Foyer
| Sponsored by: |  |
11:00-12:00 BioPartnering Leadership Session 2
- Salons E & F
Title: The Deal Machine: GSK CEEDD Deals and More
| GSK is a world leader in partnering with platform-based discovery companies through its Center for Excellence in External Discovery and Development (CEEDD). Moncef Slaoui, GSK’s Chairman of R&D will interact with panelists and the audience on GSK CEEDD philosophy and criteria for partnering. The panelists will compare/contrast CEEDD deals with other deal structures and experiences. |   |
Chair: Mr. William J Kridel, Managing Director, Ferghana Partners Group
Speaker: Mr. Jeffrey P Brennan, Vice President, Business and Commercial Development, Targacept, Inc.
Speaker: Mr. Paul J Hastings, President & Chief Executive Officer, OncoMed Pharmaceuticals
Speaker: Mr. John L Higgins, President & CEO, Ligand Pharmaceuticals Inc.
Speaker: Dr. Thomas J Schall, President & CEO, ChemoCentryx
Speaker: Dr. Moncef Slaoui, Chairman Research & Development, GlaxoSmithKline
12:15-13:15 Hot Buffet Lunch
- Salons B & C
Come enjoy our superfoods-themed lunch, including a hot buffet of turkey scaloppini with char-grilled vegetables, spinach pilaf, green tea infused coho salmon filet, and pan seared maple glazed yams with swiss chard. Finish your experience with chocolate raspberry bread pudding and blueberry mascarpone mousse tarts.
13:15-13:30 BIOTECanada & TVG Student Bursary Awards Ceremony
- Salons E & F
| TVG is strongly committed to the Canadian biotechnology industry. Together with BIOTECanada, we finance full scholarships to allow students from across Canada to attend BPN. We invest in Canadian biotech now because we believe in the future of a vibrant biotech industry of Canada. The recipients of the scholarships will be introduced. |
|
13:15-17:15 Podium Presentations - Stream 1
- Cowichan Room
In this dedicated presentation room, biotechnology companies from around the world will introduce their companies, their key technologies, products and clinical developments, as well as state their companies' partnering and financing goals.
13:15 EuraSanté - France
13:30 CYTOO cell architects - France
13:45 LEO Pharma A/S - Denmark
14:00 Vakzine Projekt Management GmbH - Germany
14:15 Congenix LLP - Russia
14:30 Cellvax - France
14:45 Topica Pharmaceuticals - USA
15:00 Novozymes - Denmark
15:15 Alligator Bioscience AB - Sweden
15:30 Alphora Research Inc. - Canada
15:45 ProtAffin Biotechnologie AG - Austria
16:00 Conformetrix - United Kingdom
16:15 PolyMedix Inc. - USA
16:30 Eurand, Inc. - Italy
16:45 Allostera Pharma Inc. - Canada
17:00 PhysioStim - France
13:15-17:15 Podium Presentations - Stream 2
- Coquitlam Room
In this dedicated presentation room, biotechnology companies from around the world will introduce their companies, their key technologies, products and clinical developments, as well as state their companies' partnering and financing goals.
13:15 PATH - USA
13:30 Synergy Pharmaceuticals - USA
13:45 GlobalTox - Canada
14:00 Oncolytics Biotech Inc. - Canada
14:15 Crown Bioscience Inc - USA
14:30 Agere Pharmaceuticals - USA
14:45 Inimex Pharmaceuticals, Inc. - Canada
15:00 Ora, Inc. - USA
15:15 InCode BioPharmaceutics, Inc. - USA
15:30 Vifor Pharma - Canada
15:45 AAIPharma Inc. - USA
16:00 Valocor Therapeutics - Canada
16:15 Forma Therapeutics, Inc. - USA
16:30 Elan Drug Technologies - USA
16:45 Augurex Life Sciences Corp. - Canada
17:00 Emerald BioStructures - USA
13:30-14:30 BioPartnering Leadership Session 3
- Salons E & F
Title: Growing Biotech on a Harsh Canadian Landscape
| After many years of sustained growth and development, Canadian Biotechnology companies, like those around the world confronted very challenging conditions in 2009. But despite these times, several Canadian companies have been able to successfully execute creative business models and secure landmark partnerships including the largest biotech partnership deal in Canadian History. Our panelist will delve into their stories, and share just what it took to break through the national and international economic climate and get these deals done. |  |
Chair: Mr. James P Hatton, Senior Partner, Lawyer, Farris, Vaughan, Wills & Murphy LLP
Speaker: Mr. Scott Cormack, President & Chief Executive Officer, OncoGenex Pharmaceuticals, Inc.
Speaker: Dr. Erich Mohr, Chairman & Chief Executive Officer, MedGenesis Therapeutix Inc.
Speaker: Mr. Bob Rieder, Executive Chairman, Cardiome Pharma Corp
Speaker: Mr. Dean Rockwell, CEO, BC Innovation Council
14:00-15:30 Workshop - hosted by Gowling Lafleur Henderson & PricewaterhouseCoopers
- Mackenzie Room
Title: Road to Recovery
| PricewaterhouseCoopers and Gowlings Lafleur Henderson are proud to bring you the next installment of the Road to Recovery series. In this session, a panel of local executives will highlight how their businesses successfully weathered the instability of 2009. Panel members will share their lessons learned and look at the challenges that lay ahead, on the road to recovery. The panel will be hosted by Peter Fairey of Gowling Lafleur Henderson LLP and Ian Heine, BC Life Sciences services leader for PricewaterhouseCoopers LLP. |
|
Welcome Remarks:
Dr. Paul Barran, NRC ITA Vancouver
Peter Brenders - President & CEO BIOTECanada
Simon Pimstone, CEO, Xenon / Chair Lifesciences BC
Company Presentations
Sam Abraham, VP Strategic Relations, BCCA
Ali Tehrani, President and CEO, Zymeworks
Andrew Rae, President and CEO, iCo Therapeutics
Panel Discussion
Sam Abraham, VP Strategic Relations, BCCA
Ali Tehrani, President and CEO, Zymeworks
Andrew Rae, President and CEO, iCo Therapeutics
Dan Polonenko - Patent Agent Gowlings Vancouver
Peter Fairey - Partner Business Law Gowlings Vancouver
Ian Heine, Partner PwC
Peter Guo, Partner, PwC
Chair: Dr. Paul Barran, Industrial Technology Advisor, National Research Council of Canada Industrial Research Assistance Program
Speaker: Dr. Samuel Abraham, Vice President, Strategic Relations, BC Cancer Agency
Speaker: Mr. Peter Fairey, Partner, Gowling Lafleur Henderson LLP
Speaker: Mr. Peter Guo, Partner, PricewaterhouseCoopers
Speaker: Mr. Ian D Heine, Partner, PricewaterhouseCoopers LLP
Speaker: Dr. Simon Pimstone, President & Chief Executive Officer, Xenon
Speaker: Mr. Daniel R Polonenko, Principal, Patent Agent, Gowling Lafleur Henderson
Speaker: Mr. Andrew J Rae, President, CEO and Director, iCo Therapeutics, Inc.
Speaker: Dr. Ali Tehrani, President & CEO, Zymeworks
15:30-16:30 BioPartnering Leadership Session 4
- Salons E & F
Title: INDIA – The Land of Opportunities
| This session will bring together the life sciences leaders from Government, Academia, Industry and Industry organizations in panel discussion. The panelists will provide a clear picture of the Indian life sciences landscape. There will be a discussion on the business and research collaboration opportunities available to Canadian and other foreign companies take advantage of the growing market and more importantly the growing industry. Attendees will also have the opportunity to engage with the panel in a Q&A session. |
|
Chair: Dr. Manu Jaggi, Director, Dabur Research Foundation
Speaker: Dr. S. Natesh, Senior Adviser, Department of Biotechnology, Ministry of Science and Technology
Speaker: Dr. Dinakar M Salunke, Executive Director, Indian Institute of Immunology
Speaker: Dr. D Sengupta, Senior Advisor, Confederation of Indian Industry
16:30-17:30 Workshop - hosted by BioAlberta
- Mackenzie Room
Title: Spirit to Achieve. Freedom to Create. MEET ALBERTA OPPORTUNITIES
| Have a few refreshments, network, and hear about
the exciting opportunities in Alberta. This workshop will profile activities within Alberta’s world-class health and biotechnology institutes as well as showcase companies that are active in the region. Join us to explore Alberta’s opportunities. |
 |
Speaker: Mr. Ken H Boutilier, President, Innovotech Inc.
Speaker: Dr. Mark Redmond, Chief Executive Officer, TheraCarb Inc.
17:30-17:45 Transportation to the Chan Centre
Buses depart from the front of the Westin Bayshore Resort for the Reception.
17:45-20:00 Reception at the Chan Centre for Performing Arts
- University of British Columbia
Title: Spotlight on the BC Bio-Economy
| The Government of British Columbia and LifeSciences BC are pleased to invite all delegates to the BioPartnering North America Gala Reception. British Columbia is home to one of the most vibrant biotechnology centres in North America; and via its world-class research, track record of commercial success, and international partnerships is fast becoming a global life sciences leader. LifeSciences British Columbia is an industry-funded association that supports and represents the biopharmaceutical, medical device, bioproducts and bioenergy, and greater life sciences community of British Columbia. Working closely with its nine international offices, the BC Government seeks to promote trade, investment and strategic partnerships in the life sciences sector. |
 |
19:30-20:00 Transportation back to the Westin Bayshore Resort
Tuesday, 26 January
07:30-16:00 Registration
- Foyer Hallway
07:30-10:30 British-Style Breakfast
- Grand Foyer
| Sponsored by: |  |
Stop by the Grand Foyer on your way to meetings and sessions for a delicious breakfast inspired by British cuisine! We will feature scrambled eggs with cheddar cheese, bacon, bangers and mash, baked beans, and grilled tomatoes and mushrooms. Help yourselves to toast and marmalade, tea and English biscuits, and an assortment of scones. Assorted juices, teas, and freshly-brewed Starbucks coffee will also be available.
09:00-17:00 Exhibition Hall: Spotlight on Biotechnology
- Salon D
1. Pharmatek Laboratories, Inc. - USA
2. Globe Laboratories Inc - Canada
3. Department of Biotechnology and Confederation of Indian Industry - Canada
4. Silence Therapeutics AG - Germany
5. Italian Trade Commission - Ontario
6. French Trade Commission - UBIFRANCE - Canada
7. BioCentury Publications - USA
8. Deloitte - USA
9. Alphora Research Inc. - Canada
10. PROOF Centre of Excellence - Canada
11. Piramal Healthcare - Canada
12. Korea International Trade Association (KITA) - Korea
13. CIRION Clinical Trial Services - Canada
14. Zoomedia - USA
09:00-12:15 Podium Presentations - Stream 1
- Cowichan Room
In this dedicated presentation room, biotechnology companies from around the world will introduce their companies, their key technologies, products and clinical developments, as well as state their companies' partnering and financing goals.
09:00 Shanghai Medicilon Inc. - China
09:15 Angiochem - Canada
09:45 University of Manitoba - Technology Transfer Office - Canada
10:00 Teva Pharmaceutical Industries Ltd. - USA
10:15 Rose Pharma A/S - Ireland
10:30 Zymeworks - Canada
10:45 KAI Pharmaceuticals Inc. - USA
11:00 iPierian - USA
11:15 Sirona Biochem - Canada
11:45 London Genetics Ltd - United Kingdom
09:00-12:15 Podium Presentations - Stream 2
- Coquitlam Room
In this dedicated presentation room, biotechnology companies from around the world will introduce their companies, their key technologies, products and clinical developments, as well as state their companies' partnering and financing goals.
09:00 Debiopharm SA - Switzerland
09:30 Sernova Corp - Canada
09:45 Aquinox Pharmaceuticals Inc. - Canada
10:15 Daiichi Sankyo Inc. - Japan
10:30 YM BioSciences Inc. - Canada
10:45 Sandoz GmbH - Germany
11:00 DSM BIOSOLUTIONS - Netherlands
11:15 Nektar Therapeutics - USA
11:30 Emmaus Medical, Inc. - USA
09:30-10:30 BioPartnering Leadership Session 5
- Salons E & F
Title: Where The Rubber (Money) Hits The Road
Venture capitalists and CFOs have their fingers on the pulse of economic activity in the life science industry. The vcs know who’s up, who’s down, and most importantly they are placing bets on people, companies, and technologies. The CFOs are allocating these funds to grow and develop their companies. Both groups have a shared interest in success. Both groups are on the front-line of the realities that face biotech companies every day. They know where and how the rubber (money) hits the road. A select panel of leading vcs and a leading CFO will take the pulse of our industry and give us the news at the start of 2010 – good, bad and indifferent. The session is moderated by a 20 year veteran of the global life science industry.
Chair: Dr. Robert Lee Kilpatrick, Partner, TVG
Speaker: Dr. Jeff Calcagno, Principal, Scale Venture Partners
Speaker: Mr. John M Dunn, Executive Vice President, New Ventures, Biogen Idec
Speaker: Mr. Richard Meadows, Managing Partner, CTI Life Sciences Fund
Speaker: Mr. Scott Wolchko, Chief Financial Officer, Fate Therapeutics
10:30-11:30 Workshop - hosted by KoreaBio
- Mackenzie Room
Title: The Business Opportunity with Asian Bioindustry in 2010
Chair: Dr. Moon-Hi Han, President, Honor president of Korea Biotechnology Industry Organization, Proteogen, Inc.
Speaker: Dr. Jong-Myung Cho, President, Crystal Genomics
Speaker: Dr. Paul Kim, Vice President, Viromed Co., Ltd.
Speaker: Dr. In-Young Ko, President, Chuncheon Bioindustry Foundation
10:30-17:00 Coffee & Tea Service
- Grand Foyer
| Sponsored by: | |
11:00-11:20 Pharmaceutical Presentation - Merck & Co., Inc.
- Salons E & F
Title: Navigating the Moguls of Deal Making - Tips from Big Pharma Perspective
| In this presentation, the speaker will highlight the strengths of their company, which may include a company overview, an outline of products on the market, and information about alliances, existing or sought. |  |
Speaker: Dr. Jane Devereux, Senior Director, Corporate Licensing, Merck & Co., Inc.
11:25-11:45 Pharmaceutical Presentation - Bristol-Myers Squibb Company
- Salons E & F
Title: Partnering with BMS
Dr. Eric Hagestad, Executive Director, Strategic Transactions will review Bristol-Myers Squibb Company's biopharma strategy, and describe some of the recent transactions done under the String of Pearls umbrella.
Speaker: Dr. Eric Hagestad, Executive Director, Strategic Transactions, Bristol-Myers Squibb Company
11:50-12:10 Pharmaceutical Presentation - Pfizer
- Salons E & F
Title: The Pfizer Incubator: Early-Stage Financing in a Changing Environment
| In this presentation, the speaker will highlight the strengths of their company, which may include a company overview, an outline of products on the market, and information about alliances, existing or sought. |  |
Speaker: Dr. Mark J Benedyk, Senior Director, Pfizer
12:15-13:15 Hot Buffet Lunch
- Salons B & C
Continue your networking while dining on a hot buffet of antipasto, mixed greens and roasted vegetables; thyme marinated chicken breast with red wine and woodland mushroom sauce; and, penne pasta with spring salmon, bayshrimp, scallops, and pacific coast snapper in a light dill sauce. Complete your experience with a serving of almond strawberry shortcake.
13:15-14:15 Workshop - hosted by the CDRD, CQDM, & MaRS
- Mackenzie Room
Title: Bridging the Commercialization Gap: New Models of Collaborative Drug Development in Canada
Chair: Ms. Natalie Dakers, President & CEO, Centre for Drug Research & Development (CDRD)
Speaker: Dr. Max Fehlmann, President & CEO, Québec Consortium for Drug Discovery (CQDM)
Speaker: Dr. Rafi Hofstein, President & CEO, MaRS Innovation
13:15-16:00 Podium Presentations - Stream 1
- Cowichan Room
In this dedicated presentation room, biotechnology companies from around the world will introduce their companies, their key technologies, products and clinical developments, as well as state their companies' partnering and financing goals.
13:30 Araclon Biotech - Spain
13:45 Allon Therapeutics Inc. - Canada
14:00 SuperGen Inc. - USA
14:15 Porsolt & Partners Pharmacology - France
14:30 Alsace BioValley - France
14:45 Metabolys - France
15:00 OxyPharma - Sweden
15:15 NDA Regulatory Service AB - United Kingdom
13:30-13:50 Pharmaceutical Presentation - AstraZeneca
- Salons E & F
| In this presentation, the speaker will highlight the strengths of their company, which may include a company overview, an outline of products on the market, and information about alliances, existing or sought. |  |
Speaker: Dr. Magnus Björsne, Business Development Director, AstraZeneca
13:55-14:15 Pharmaceutical Presentation - Roche
- Salons E & F
Title: What Roche Is Looking For
| In this presentation, the speaker will highlight the strengths of their company, which may include a company overview, an outline of products on the market, and information about alliances, existing or sought. |  |
Speaker: Dr. Joyce Pei, Director, Global Business Development, Roche
14:20-14:40 Pharmaceutical Presentation - Crucell
- Salons E & F
| In this presentation, the speaker will highlight the strengths of their company, which may include a company overview, an outline of products on the market, and information about alliances, existing or sought. |  |
Speaker: Mr. Sven Lee, Director Business Development, Crucell
14:45-15:45 Workshop - hosted by the Italian Trade Commission
- Mackenzie Room
Title: Italian Biotech Industry: Now and Future
16:00-17:00 BioForecaster
- Salons E & F
Title: Future Trends in 2010
A complete review of the Life and Health Sciences sector across North America. Metrics will be presented and leading members of the professional investment community will provide commentary and predictions for the coming six months.
Chair: Mr. Jeremy Webster, National Leader of Biotechnology, Deloitte
17:00-18:00 Farewell Drinks Reception
- Grand Foyer
An opportunity to say goodbye to fellow delegates and begin planning for the 9th Annual BioPartnering North America.
|
|
|
|
|
|
 |
||||
|
||||
 |
||||
|
CONNECT: |
||||
© Copyright 2009 • Technology Vision Group LLC • All rights reserved.